Status:
UNKNOWN
Simulation in Transurethral Bladder Cancer Surgery
Lead Sponsor:
Rigshospitalet, Denmark
Collaborating Sponsors:
Copenhagen Academy for Medical Education and Simulation
Conditions:
Virtual Reality
Education
Eligibility:
All Genders
20-70 years
Phase:
NA
Brief Summary
Bladder cancer (BC) is the seventh most common cancer disease among men worldwide, and the fourth most common cancer in Danish men with an incidence of more than 2000 and a prevalence of 650 per 10000...
Detailed Description
Doctors' surgical skills have consequences for patients outcomes and continued training and assessment of surgeons has the potential to improve patient safety and shorten learning curves in the operat...
Eligibility Criteria
Inclusion
- Doctors
- Informed written consent.
- Four video-recordings of TURBs.
Exclusion
- Not providing four video recordings of TURB procedures
- Simulation-based training course in TURB within 6 months
- No consent
Key Trial Info
Start Date :
June 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT03864302
Start Date
June 1 2019
End Date
December 31 2022
Last Update
August 24 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Urology Department Zealand University Hospital
Roskilde, Danmark, Denmark, 4000